Explore chapters and articles related to this topic
Emerging Trends in Nanotechnology for Diagnosis and Therapy of Lung Cancer
Published in Alok Dhawan, Sanjay Singh, Ashutosh Kumar, Rishi Shanker, Nanobiotechnology, 2018
Nanda Rohra, Manish Gore, Sathish Dyawanapelly, Mahesh Tambe, Ankit Gautam, Meghna Suvarna, Ratnesh Jain, Prajakta Dandekar
Tumors in the early stages I and II of non–small cell lung cancer (NSCLC) can be successfully removed surgically by anatomic segmentectomy, wedge resection, lobectomy, or pneumonectomy (Lang-Lazdunski 2013). These techniques are described below.
Prediction and validation of survival rate of metachronous second primary lung cancer patients using machine learning classifiers
Published in Smart Science, 2023
Priyanka Ramesh, Shanthi Veerappapillai
LSP describes the type of surgery used for treating cancer in the primary site. This is study involves five different categories of LSP process. Category 1 includes patients who haven’t undergone any surgical processes. Categories 2 and 3 depict surgery through pneumonectomy and lobectomy approaches. Consequently, categories 4 and 5 describe the other surgical approaches and unclassified cohort, respectively. In our study, we can observe from the Figure 5d that the survival of patients undergone lobectomy remained higher till 5 years than other surgical strategies. The other categories remained similar till 5 years of time period. On the hand, a sudden drop in curve for categories 2 and 5 was observed is mainly due to the lack of data corresponds to the patients of that particular categories. In case of 10-year survival analysis, 20% of patient undergone pneumonectomy remained stable at the end than the other approaches. However, more data with surgical treatment are necessary to provide feasible interpretation.
Comparison of mechanical cardiopulmonary support strategies during lung transplantation
Published in Expert Review of Medical Devices, 2020
Noah Weingarten, Dean Schraufnagel, Gilman Plitt, Anthony Zaki, Kamal S. Ayyat, Haytham Elgharably
Twelve studies compared PGD or its components – hypoxemia and pulmonary infiltrates – in patients transplanted on CPB versus those transplanted off pump. Seven of eight studies comparing PGD rates between CPB and off pump found increased rates associated with CPB [60–66]. One outlying study, which examined outcomes among patients undergoing bilateral LT for cystic fibrosis, found no difference in rates of PGD between CPB and off pump recipients [48]. The authors link this unexpected outcome to the fact that CPB decreases graft infection by enabling bilateral pneumonectomy and proximal airway decontamination prior to graft implantation in patients at high risk of septic lung disease.